Morgan Stanley
-
Bain Capital has given in to a laundry list of demands from investors as they snubbed bonds for Kantar, resulting in a delay to the deal's schedule. In a rare case of aggressive investor push-back, covenants have now been flexed to the extreme and initial price thoughts look surprisingly high, given the exceptionally favourable market for new issuers.
-
The stars aligned for French drink company Pernod Ricard’s return to the bond market, with the issuer printing flat to its curve, or even through it by some estimates, in its first outing since being upgraded by two credit rating agencies.
-
Streaming giant Netflix is in the market for $2bn with a 10.5-year bond issue split between euros and dollars. The unsecured senior notes come with a non-call life clause, offered to investors as a carrot.
-
France’s Pernod Ricard is in the market on Monday for a €1.5bn trade, with the drinks company striking while the iron is hot to print debt after being upgraded by two agencies last week.
-
ESR Cayman, a warehouse construction firm and lessor, has boldly returned with a bigger IPO target after delaying its first go at listing earlier this year.
-
Small appliance maker JS Global Lifestyle Co has opened the books for a Hong Kong IPO. It hopes to raise up to HK$3.6bn ($462.1m), according to a source close to the deal.
-
Chinese firm InnoCare Pharma is looking for permission to list in Hong Kong, having filed a draft IPO prospectus with the city’s stock exchange.
-
BMW Finance returned to the Panda bond market with a Rmb3bn ($424m) dual-tranche private placement note. It was the company's third outing this year, but this time the German automaker substituted the three year tranche with a two year note.
-
Argenta Spaarbank’s trade this week was a warning to smaller banks about the importance of good pricing and roadshows in selling bonds. But even for those issuers willing to heed those lessons, it may already be too late to issue debt, writes David Freitas.
-
Bank of America became the first big US bank to emerge from third quarter earnings blackout and tap the dollar bond market this week.
-
Morgan Stanley posted fee growth in underwriting and advisory in its third quarter results on Thursday, leaving Goldman Sachs the outlier among the five big US banks in seeing revenues fall in investment banking.
-
Allergan shareholders have waved through its acquisition by rival drug company AbbVie, clearing a major hurdle on the way to billions of dollars of loans and an expected $30bn of bond issuance.